Hepatitis C Virus (HCV) Antibody, IgM

The Hepatitis C Virus (HCV) Antibody, IgM assay (anti-HCV IgM; HCV IgM antibody) assists in diagnosing acute or recent HCV infection and in assessing disease activity or reactivation when clinically suspected. It is most informative when reviewed alongside HCV RNA by PCR, alanine/aspartate aminotransferases, and other hepatitis serologic markers. In the differential diagnosis of viral hepatitis, anti-HCV IgM helps distinguish HCV-related disease from other etiologies when integrated with molecular testing and hepatic biochemistry.

Hepatitis C virus is an RNA virus in the Flaviviridae family with hepatotropism and the ability to replicate in hematopoietic cells, including neutrophils, monocytes/macrophages, and B lymphocytes. Infection is linked to mixed cryoglobulinemia, Sjögren syndrome, and B‑cell lymphoproliferative disorders. Substantial genetic diversity—at least 6 genotypes with multiple subtypes—together with a high mutation rate promotes immune escape and influences prognosis and response to antiviral therapy. Transmission occurs primarily through blood exposure, such as transfusion, transplantation, use of nonsterile injection equipment, and contaminated tattooing or piercing instruments; sexual and perinatal spread are less common. Acute infection is frequently silent, with only a minority developing constitutional symptoms and, less often, jaundice. Most infected individuals progress to chronic infection, which can evolve over years to cirrhosis, hepatic failure, and hepatocellular carcinoma. Humoral responses target core, envelope (E1–E2), and nonstructural (NS) proteins. Anti‑HCV IgM typically appears 4–6 weeks after infection, peaks early, and then declines by about 5–6 months; it may reappear during reactivation. Persistence of IgM beyond approximately two months suggests possible chronicity. Because seronegativity can be present early after exposure or rarely persist, nucleic acid amplification testing for HCV RNA is recommended to clarify infection status, gauge disease activity, and for ongoing monitoring.